- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS (GENIL)
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS stock price live, this page displays IS GENIL stock exchange data. View the GENIL premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS real time stock price chart below.
What Is the Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Stock Price Today?
The Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS stock price today is 179.60.
What Is the Stock Symbol for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS?
The stock symbol for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS is ""GENIL.""
What Stock Exchange Does Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Trade On?
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS is listed and trades on the Istanbul stock exchange.
Is Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS a Good Stock to Buy?
Determining whether Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GENIL quote. (ISIN: TREGENL00024)
What Is the Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Stock Price Today?
The Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS stock price today is 179.60.
What Is the Stock Symbol for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS?
The stock symbol for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS is ""GENIL.""
What Stock Exchange Does Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Trade On?
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS is listed and trades on the Istanbul stock exchange.
Is Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS a Good Stock to Buy?
Determining whether Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GENIL quote. (ISIN: TREGENL00024)
Istanbul
Currency in TRY
179.60
-19.90(-9.97%)
Delayed Data·
Fair Value
An estimate of a Gen İlaç ve Sağlık Ürünleri's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
179.60
199.50
52 wk Range
79.65
203.96
GENIL Scorecard
Full Analysis
Trading at a high earnings multiple
GENIL is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Gen İlaç ve Sağlık Ürünleri's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
179.60199.50
52 wk Range
79.65203.96
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.32%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.32%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
GENIL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Gen İlaç ve Sağlık Ürünleri's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Neutral
Price Target
103.87
Downside
-42.17%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Company Profile
Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi, a pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide. The company offers its products in various areas, such as neurology, endocrinology, nephrology, oncology, hematology, and pediatric. Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi has collaboration with Sulfateq BV for the development of molecule SUL-238 as a treatment for Alzheimer's disease and other neurodegenerative diseases. The company was incorporated in 1997 and is headquartered in Çankaya, Turkey.
Compare GENIL to Peers and Sector
Metrics to compare | GENIL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGENILPeersSector | |
|---|---|---|---|---|
P/E Ratio | 219.7x | −5.8x | −0.5x | |
PEG Ratio | −3.20 | 0.00 | 0.00 | |
Price/Book | 6.4x | 1.1x | 2.6x | |
Price / LTM Sales | 3.8x | 1.1x | 3.3x | |
Upside (Analyst Target) | −47.9% | 108.3% | 40.6% | |
Fair Value Upside | Unlock | 11.9% | 5.3% | Unlock |
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 103.87
(-42.17% Downside)
Earnings
Latest Release
May 09, 2025
EPS / Forecast
1.07 / --
Revenue / Forecast
3.86B / --
People Also Watch
FAQ
What Stock Exchange Does Gen İlaç ve Sağlık Ürünleri Trade On?
Gen İlaç ve Sağlık Ürünleri is listed and trades on the Istanbul Stock Exchange stock exchange.
What Is the Stock Symbol for Gen İlaç ve Sağlık Ürünleri?
The stock symbol for Gen İlaç ve Sağlık Ürünleri is "GENIL."
What Is the Gen İlaç ve Sağlık Ürünleri Market Cap?
As of today, Gen İlaç ve Sağlık Ürünleri market cap is 59.85B.
What Is Gen İlaç ve Sağlık Ürünleri's Earnings Per Share (TTM)?
The Gen İlaç ve Sağlık Ürünleri EPS (TTM) is 0.82.
From a Technical Analysis Perspective, Is GENIL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Gen İlaç ve Sağlık Ürünleri Stock Split?
Gen İlaç ve Sağlık Ürünleri has split 0 times.
How Many Employees Does Gen İlaç ve Sağlık Ürünleri Have?
Gen İlaç ve Sağlık Ürünleri has 639 employees.
What is the current trading status of Gen İlaç ve Sağlık Ürünleri (GENIL)?
As of 15 Aug 2025, Gen İlaç ve Sağlık Ürünleri (GENIL) is trading at a price of 179.60, with a previous close of 199.50. The stock has fluctuated within a day range of 179.60 to 199.50, while its 52-week range spans from 79.65 to 203.96.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.